The current treatment for Alzheimer’s disease (AD) is acetylcholinesterase (AChE) inhibitors, which partially block the degradation of ACh in the synapse and enable more of the neurotransmitter to reach and activate cholinergic receptors [64]. The gene discussed is ACHE; the disease is Alzheimer disease.